MusclePharm Strengthens Retail Presence With GNC
June 24 2014 - 8:05AM
Marketwired
MusclePharm Strengthens Retail Presence With GNC
All MusclePharm Brands to Be Carried in 4,000+ U.S. Domestic GNC
Corporate Stores; Products to Be Featured on Dedicated Wall Within
GNC
DENVER, CO--(Marketwired - Jun 24, 2014) - MusclePharm
Corporation (OTCQB: MSLP), a scientifically driven,
performance-lifestyle sports nutrition company, today announced an
expanded relationship with GNC (NYSE: GNC), a leading global
specialty retailer of health and wellness products, to carry all of
MusclePharm's brands -- MusclePharm® Hybrid and Core Series, Arnold
Schwarzenegger Series™ and FitMiss® -- on a dedicated wall in all
of GNC's U.S. corporate stores. The new initiative is expected to
begin during MusclePharm's 2014 third quarter.
"I am excited about the expanded commitment and partnership with
GNC, nearly doubling the number of stores carrying our brands to
more than 4,000, and extending our relationship to include all of
our brands with the addition of FitMiss," said Brad Pyatt, chief
executive officer of MusclePharm. "Our increased in-store and
online presence, which is set to begin in third quarter, will be
further supported through a unique and aggressive sales and
marketing program."
"MusclePharm, recognized by GNC in 2012 with our exclusive
Rising Star vendor award, utilizes innovative social media and
digital marketing and a robust stable of notable athletes, fitness
enthusiasts and brand ambassadors to reach and educate its
customers and targets," said Joe Fortunato, chairman, president and
CEO of GNC. "We are looking forward to our partnership with
MusclePharm to complement each other's strengths, drive traffic and
reach a broader global market."
About MusclePharm MusclePharm® is a scientifically driven,
performance-lifestyle company that currently develops,
manufactures, markets and distributes branded nutritional
supplements. The company offers a complete range of powders,
capsules, tablets and gels. Its portfolio of recognized brands,
including MusclePharm® Hybrid and Core Series, Arnold
Schwarzenegger Series™ and FitMiss®, are marketed and sold in more
than 110 countries and available in over 35,000 retail outlets
globally. These clinically-proven and scientific nutritional
supplements are developed through a six-stage research process
utilizing the expertise of leading nutritional scientists, doctors
and universities. MusclePharm is the innovator of the sports
nutrition industry. For more information, visit
www.musclepharm.com
Follow the company at http://www.facebook.com/MusclePharm and
www.Twitter.com/MusclePharm
To sign up to receive MusclePharm news via email, please visit
http://ir.musclepharmcorp.com/email-alerts
Forward-Looking Statements This release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities and Exchange
Act of 1934, as amended. Statements that are not a description of
historical facts constitute forward-looking statements and may
often, but not always, be identified by the use of such words as
"expects", "anticipates", "intends", "estimates", "plans",
"potential", "possible", "probable", "believes", "seeks", "may",
"will", "should", "could" or the negative of such terms or other
similar expressions. Actual results may differ materially from
those set forth in this release due to the risks and uncertainties
inherent in the Company's business. More detailed information about
the Company and the risk factors that may affect the realization of
forward-looking statements is set forth in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2013,
the Company's Quarter Reports on Form 10-Q and other filings
submitted by the Company to the SEC, copies of which may be
obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
Contacts: Matt Sheldon/Evan Pondel PondelWilkinson Inc. (310)
279-5980 investors@musclepharm.com
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2023 to Apr 2024